Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017;15(4):480-494.
doi: 10.2174/1570159X14666160325121145.

Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease

Affiliations
Review

Cholinergic System and Post-translational Modifications: An Insight on the Role in Alzheimer's Disease

Touqeer Ahmed et al. Curr Neuropharmacol. 2017.

Abstract

Background: Alzheimer's disease (AD) is the most common form of old age dementia. The formation of amyloid plaques (Aβ), neurofibrillary tangles and loss of basal forebrain cholinergic neurons are the hallmark events in the pathology of AD.

Literature review: Cholinergic system is one of the most important neurotransmitter system involved in learning and memory which preferentially degenerates in the initial stages of AD. Activation of cholinergic receptors (muscarinic and nicotinic) activates multiple pathways which result in post translational modifications (PTMs) in multiple proteins which bring changes in nervous system. Cholinergic receptors-mediated PTMs "in-part" substantially affect the biosynthesis, proteolysis, degradation and expression of many proteins and in particular, amyloid precursor protein (APP). APP is subjected to several PTMs (proteolytic processing, glycosylation, sulfation, and phosphorylation) during its course of processing, resulting in Aβ deposition, leading to AD. Aβ also alters the PTMs of tau which is a microtubule associated protein. Therefore, post-translationally modified tau and Aβ collectively aggravate the neuronal loss that leads to cholinergic hypofunction.

Conclusion: Despite the accumulating evidences, the interaction between cholinergic neurotransmission and the physiological significance of PTM events remain speculative and still needs further exploration. This review focuses on the role of cholinergic system and discusses the significance of PTMs in pathological progression of AD and highlights some important future directions.

Keywords: Acetylcholine; Alzheimer's disease; muscarinic receptors; nicotinic receptors; post translational modifications.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Expression of Muscarinic and Nicotinic Receptors in Brain. Abbreviations: bas: Nucleus basalis, Hippo: hippocampus, LC: locus coeruleus, PFC: Prefrontal cortex, SN: substantia nigra, VTA: ventral tegmental area [39, 40, 44, 51, 52, 76].
Fig. (2)
Fig. (2)
Cholinergic Synapse and PTMs of APP and Tau. Abbreviations: ChaT: Choline acetylTransferase, PtdCho: Phosphotidylcholine, SV: Synaptic vesicles, AChE: Acetylcholine esterase, ACh: acetylcholine, mAChR: muscarinic ACh receptor, nAChR: nicotinic ACh receptor, 1) PtdCho provides the choline precursor and acetyl moiety from acetyl CoA, 2) in the presence of ChaT 3) the ACh is synthesized, 4) Storage of ACh in synaptic vesicles, 5) Release of ACh in the synaptic cleft, 6) Action of ACh on postsynaptic cholinergic receptor, 7) Degradation of ACh via AChE into choline and acetate ion, 8) Reuptake of choline into the presynaptic nerve terminal by choline transporter.

References

    1. Jucker M., Walker L.C. Neurodegeneration: Amyloid-β pathology induced in humans. Nature. 2015;525(7568):193–194. [http://dx. doi.org/10.1038/525193a]. [PMID: 26354478]. - PMC - PubMed
    1. Selkoe D.J., Schenk D. Alzheimers disease: molecular understanding predicts amyloid-based therapeutics. Annu. Rev. Pharmacol. Toxicol. 2003;43:545–584. [http://dx.doi.org/10.1146/annurev.pharmtox.43.100901.140248]. [PMID: 12415125]. - PubMed
    1. Zilka N., Novak M. The tangled story of Alois Alzheimer. Bratisl. Lek Listy (Tlacene Vyd) 2006;107(9-10):343–345. [PMID: 17262985]. - PubMed
    1. Fu W., Jhamandas J.H. β-amyloid peptide activates non-α7 nicotinic acetylcholine receptors in rat basal forebrain neurons. J. Neurophysiol. 2003;90(5):3130–3136. [http://dx.doi.org/10.1152/ jn.00616.2003]. [PMID: 12890800]. - PubMed
    1. Glenner G., Wong C. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Alzheimer Dis. Assoc. Disord. 1988;2(2):134. - PubMed

MeSH terms